129
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of Risk Factors for Bleeding After Ultrasound-Guided Liver Biopsy

, , , , , , , , & ORCID Icon show all
Pages 5563-5571 | Published online: 11 Sep 2021

References

  • Bedossa P. Liver biopsy. Gastroenterol Clin Biol. 2008;32(6 Suppl 1):4–7. doi:10.1016/S0399-8320(08)73989-7
  • Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7):495–500. doi:10.1056/NEJM200102153440706
  • Khalifa A, Rockey DC. The utility of liver biopsy in 2020. Curr Opin Gastroenterol. 2020;36(3):184–191. doi:10.1097/MOG.0000000000000621
  • Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver D. Liver biopsy. Hepatology. 2009;49(3):1017–1044. doi:10.1002/hep.22742
  • Copel L, Sosna J, Kruskal JB, Kane RA. Ultrasound-guided percutaneous liver biopsy: indications, risks, and technique. Surg Technol Int. 2003;11:154–160.
  • Nobili V, Comparcola D, Sartorelli MR, et al. Blind and ultrasound-guided percutaneous liver biopsy in children. Pediatr Radiol. 2003;33(11):772–775. doi:10.1007/s00247-003-1044-0
  • Rustagi T, Newton E, Kar P. Percutaneous liver biopsy. Trop Gastroenterol. 2010;31(3):199–212.
  • Tian G, Kong D, Jiang T, Li L. Complications after percutaneous ultrasound-guided liver biopsy: a systematic review and meta-analysis of a population of more than 12,000 patients from 51 cohort studies. J Ultrasound Med. 2020;39(7):1355–1365. doi:10.1002/jum.15229
  • Al Knawy B, Shiffman M. Percutaneous liver biopsy in clinical practice. Liver Int. 2007;27(9):1166–1173. doi:10.1111/j.1478-3231.2007.01592.x
  • Sornsakrin M, Helmke K, Briem-Richter A, Ganschow R. Value of ultrasound-guided percutaneous liver biopsy in children following liver transplantation. J Pediatr Gastroenterol Nutr. 2010;51(5):635–637. doi:10.1097/MPG.0b013e3181e7e832
  • Kim JS, Won HJ, Lee SJ, Kim SY, Shin YM, Kim PN. Utility and safety of repeated ultrasound-guided core needle biopsy of focal liver masses. J Ultrasound Med. 2018;37(2):447–452. doi:10.1002/jum.14358
  • Rothuizen J, Twedt DC. Liver biopsy techniques. Vet Clin North Am Small Anim Pract. 2009;39(3):469–480. doi:10.1016/j.cvsm.2009.02.006
  • Padia SA, Baker ME, Schaeffer CJ, et al. Safety and efficacy of sonographic-guided random real-time core needle biopsy of the liver. J Clin Ultrasound. 2009;37(3):138–143. doi:10.1002/jcu.20553
  • Sebagh M, Rifai K, Féray C, et al. All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology. 2010;37(6):1293–1301.
  • Poorten D, Kwok A, Lam T, Ridley L, Lee AU. Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J. 2010;36(11):692–699. doi:10.1111/j.1445-5994.2006.01216.x
  • Seeff LB, Everson GT, Morgan TR, Curto TM, Dienstag JL. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010;8(10):877–883. doi:10.1016/j.cgh.2010.03.025
  • Takyar V, Etzion O, Heller T, et al. Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience. Aliment Pharmacol Ther. 2017;45(5):744–753. doi:10.1111/apt.13939
  • Chi H, Hansen BE, Tang WY, et al. Multiple biopsy passes and the risk of complications of percutaneous liver biopsy. Eur J Gastroenterol Hepatol. 2017;29(1):36–41. doi:10.1097/MEG.0000000000000731
  • Bilreiro C, Noruegas MJ, Goncalves I, Moreira A. Ultrasound-guided liver biopsies in children: a single-center experience and risk factors for minor bleeding. J Pediatr Gastroenterol Nutr. 2017;65(2):137–140. doi:10.1097/MPG.0000000000001601
  • Kim KW, Kim MJ, Kim HC, Park SH, Kim TK. Value of “patent track” sign on Doppler sonography after percutaneous liver biopsy in detection of postbiopsy bleeding: a prospective study in 352 patients. Am J Roentgenol. 2007;189(1):109–116. doi:10.2214/AJR.07.2071
  • Midia M, Odedra D, Shuster A, et al. Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review. Diagn Interv Radiol. 2019;25(1):71–80. doi:10.5152/dir.2018.17525
  • Westheim BH, Aagenaes I, Ostensen AB, Sanengen T, Almaas R. Effect of operator experience and frequency of procedure performance on complication rate after ultrasound-guided percutaneous liver biopsies. J Pediatr Gastroenterol Nutr. 2013;57(5):638–643. doi:10.1097/MPG.0b013e3182a0c7a5
  • Myers RP, Fong A, Shaheen A. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. 2010;28(5):705–712. doi:10.1111/j.1478-3231.2008.01691.x
  • Huang JF, Hsieh MY, Dai CY, et al. The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies. Gut. 2007;56(5):736–737. doi:10.1136/gut.2006.115410
  • Westheim BH, Ostensen AB, Aagenaes I, Sanengen T, Almaas R. Evaluation of risk factors for bleeding after liver biopsy in children. J Pediatr Gastroenterol Nutr. 2012;55(1):82–87. doi:10.1097/MPG.0b013e318249c12a
  • Mueller M, Kratzer W, Oeztuerk S, et al. Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol. 2012;12:173. doi:10.1186/1471-230X-12-173
  • Yu SC, Metreweli C, Lau WY, et al. Safety of percutaneous biopsy of hepatocellular carcinoma with an 18 gauge automated needle. Clin Radiol. 1997;52(12):907. doi:10.1016/S0009-9260(97)80222-X
  • Terjung B, Lemnitzer I, Dumoulin FL, et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion. 2003;67(3):138–145. doi:10.1159/000071293
  • Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2010;45(9):1413–1425. doi:10.1111/j.1537-2995.2005.00546.x
  • Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553–558. doi:10.1002/hep.20569
  • Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant. 2010;7(6):1624–1628. doi:10.1111/j.1600-6143.2007.01822.x
  • Lisman T, Van Leeuwen Y, Adelmeijer J, et al. Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int. 2010;28(10):1344–1351. doi:10.1111/j.1478-3231.2008.01783.x
  • Song KD, Rhim H, Lee MW, Kang TW, Lim S. A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study. Br J Radiol. 2018;91(1085):20170585. doi:10.1259/bjr.20170585
  • Sag AA, Brody LA, Maybody M, et al. Acute and delayed bleeding requiring embolization after image-guided liver biopsy in patients with cancer. Clin Imaging. 2016;40(3):535–540. doi:10.1016/j.clinimag.2015.11.004
  • Pathak K, Gopinath M, Salgotra KR. Transjugular liver biopsy. Med J Armed Forces India. 2013;69(4):384–387. doi:10.1016/j.mjafi.2013.04.003
  • Ble M, Procopet B, Miquel R, Hernandez-Gea V, Garcia-Pagan JC. Transjugular liver biopsy. Clin Liver Dis. 2014;18(4):767–778. doi:10.1016/j.cld.2014.07.001
  • Dotan Y, Carlebach M, Zuckerman E, Maruf M, Schiff E. Delayed bleeding after percutaneous liver biopsy. Eur J Case Rep Intern Med. 2016;3(2):000359.